SphingoTec is a company that develops biomarkers for diagnosis, prediction, and monitoring of acute medical conditions. It focuses on acute heart failure, acute kidney injury, and circulatory shock. In addition, the company develops biomarkers for the prediction of health risks, such as obesity, cardiovascular diseases, and breast cancer.